Gupta Raghav, Ogilvy Christopher S, Moore Justin M, Griessenauer Christoph J, Enriquez-Marulanda Alejandro, Leadon Madeline, Adeeb Nimer, Ascanio Luis, Maragkos Georgios A, Jain Abhi, Schmalz Philip G R, Alturki Abdulrahman Y, Kicielinski Kimberly, Schirmer Clemens M, Thomas Ajith J
1Neurosurgical Service, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; and.
2Department of Neurosurgery, Geisinger Medical Center, Danville, Pennsylvania.
J Neurosurg. 2019 Jul 1;131(1):32-39. doi: 10.3171/2018.2.JNS172673. Epub 2018 Jul 13.
There is currently no standardized follow-up imaging strategy for intracranial aneurysms treated with the Pipeline embolization device (PED). Here, the authors use follow-up imaging data for aneurysms treated with the PED to propose a standardizable follow-up imaging strategy.
A retrospective review of all patients who underwent treatment for ruptured or unruptured intracranial aneurysms with the PED between March 2013 and March 2017 at 2 major academic institutions in the US was performed.
A total of 218 patients underwent treatment for 259 aneurysms with the PED and had undergone at least 1 follow-up imaging session to assess aneurysm occlusion status. There were 235 (90.7%) anterior and 24 posterior (9.3%) circulation aneurysms. On Kaplan-Meier analysis, the cumulative incidences of aneurysm occlusion at 6, 12, 18, and 24 months were 38.2%, 77.8%, 84.2%, and 85.1%, respectively. No differences in the cumulative incidence of aneurysm occlusion according to aneurysm location (p = 0.39) or aneurysm size (p = 0.81) were observed. A trend toward a decreased cumulative incidence of aneurysm occlusion in patients 70 years or older was observed (p = 0.088). No instances of aneurysm rupture after PED treatment or aneurysm recurrence after occlusion were noted. Sixteen (6.2%) aneurysms were re-treated with the PED; 11 of these had imaging follow-up data available, demonstrating occlusion in 3 (27.3%).
The authors propose a follow-up imaging strategy that incorporates 12-month digital subtraction angiography and 24-month MRA for patients younger than 70 years and single-session digital subtraction angiography at 12 months in patients 70 years or older. For recurrent or persistent aneurysms, re-treatment with the PED or use of an alternative treatment modality may be considered.
目前,对于采用Pipeline栓塞装置(PED)治疗的颅内动脉瘤,尚无标准化的随访成像策略。在此,作者利用PED治疗动脉瘤的随访成像数据,提出一种可标准化的随访成像策略。
对2013年3月至2017年3月期间在美国2家主要学术机构接受PED治疗破裂或未破裂颅内动脉瘤的所有患者进行回顾性研究。
共有218例患者接受了PED治疗259个动脉瘤,且至少进行了1次随访成像检查以评估动脉瘤闭塞状态。其中前循环动脉瘤235个(90.7%),后循环动脉瘤24个(9.3%)。根据Kaplan-Meier分析,动脉瘤在6、12、18和24个月时的累积闭塞发生率分别为38.2%、77.8%、84.2%和85.1%。未观察到根据动脉瘤位置(p = 0.39)或动脉瘤大小(p = 0.81)在动脉瘤闭塞累积发生率上的差异。观察到70岁及以上患者的动脉瘤闭塞累积发生率有下降趋势(p = 0.088)。未发现PED治疗后动脉瘤破裂或闭塞后动脉瘤复发的情况。16个(6.2%)动脉瘤接受了PED再次治疗;其中11个有可用的成像随访数据,显示3个(27.3%)实现了闭塞。
作者提出一种随访成像策略,对于70岁以下患者,采用12个月数字减影血管造影和24个月磁共振血管造影;对于70岁及以上患者,在12个月时进行单次数字减影血管造影。对于复发或持续性动脉瘤,可考虑采用PED再次治疗或使用其他治疗方式。